| Humalog pen (insulin lispro) / Eli Lilly |
2011-001509-28: Efficacy and mechanisms of a short course of intensified insulin treatment on remission or responsiveness to oral therapy in type 2 diabetes Efficacia e meccanismi di un trattamento insulinico intensivo di breve durata sulla remissione o risposta alla terapia orale del diabete di tipo 2 |
|
|
| Ongoing | 4 | 75 | Europe | Solution for injection, Suspension for injection, Coated tablet, HUMALOG*BASAL 10PEN 3ML 100U/M, HUMALOG NPL=>HUMALOG BASAL, GLUCOPHAGE*30CPR RIV 500MG | AZIENDA OSPEDALIERO-UNIVERSITARIA PISANA, Eli Lilly S.p.A., Universita' di Pisa | Newly-diagnosed type 2 diabetes patients. Pazienti naive con diagnosi di diabete di tipo 2., Untreated patients with type 2 diabetes. Pazienti non trattati con diagnosi di diabete di tipo 2., Diseases [C] - Nutritional and Metabolic Diseases [C18] | | | | |
| Ongoing | 4 | 278 | Europe | Diformin retard, Protaphane Flexpen, Novorapid Flexpen, Humalog Pen, Diformin retard, Protaphane Flexpen, Novorapid Flexpen, Humalog Pen | Turku Univeristy Hospital | Raskausdiabetes | | | | |
2005-005914-18: Effect of Insulin Glulisin on postprandial plasma glucose levels in obese subjectts with type 2 diabetes after a standard meal in comparison to Insulin Lispro |
|
|
| Ongoing | 4 | 30 | Europe | Apidra, Humalog, Apidra, Humalog, Apidra, Humalog | Diabetes-Centre Quakenbrueck | Obese subjects with type 2 diabetes mellitus | | | | |
2007-005212-41: ESTUDIO COMPARATIVO DEL TRATAMIENTO CON BOMBA DE INSULINA SUBCUTANEA, INSULINA GLARGINA E INSULINA NPH EN NIÑOS DIABÉTICOS DE 0 A 6 AÑOS DE EDADComparative study between treatment with insulin pump, insulin gragina and insulin NPH in diabetic children from 0 to 6 years old. |
|
|
| Ongoing | 4 | 30 | Europe | LANTUS, HUMULINA NPH, HUMALOG, LANTUS, HUMULINA NPH, HUMALOG | HOSPITAL SANT JOAN DE DÉU | ESTUDIO COMPARATIVO DEL TRATAMIENTO CON BOMBA DE INSULINA SUBCUTANEA, INSULINA GLARGINA E INSULINA NPH EN NIÑOS DIABÉTICOS DE 0 A 6 AÑOS DE EDAD.Comparative study between treatment with insulin pump, insulin gragina and insulin NPH in diabetic children from 0 to 6 years old. | | | | |
2012-000216-28: Intensive Insulin Protocol in Renal Transplant Recipients Receiving a Tacrolimus-based Immunosuppression |
|
|
| Ongoing | 4 | 50 | Europe | Humalog, Humalog | Medizinische Universität Wien, Universitätsklinik für Innere Medizin III, Österreichische Diabetes Gesellschaft (ÖDG) | New onset diabetes after organ-transplantation | | | | |
NCT04124302: The Impact of Two Different Insulin Dose Calculation on Postprandial Glycemia After Mixed Meal. |
|
|
| Not yet recruiting | 4 | 70 | NA | Insulin Glulisine, Apidra, Insulin Aspart, NovoRapid, Insulin Lispro, Humalog, Liprolog | Medical University of Warsaw | Diabetes Mellitus, Type 1 | 08/21 | 08/23 | | |
NCT04019821: Super-Bolus: Effects on Postprandial Glycemia After High Glycemic Index Meal |
|
|
| Completed | 4 | 72 | Europe | Insulin Glulisine, Apidra, Insulin Aspart, NovoRapid, Insulin Lispro, Humalog, Liprolog | Medical University of Warsaw | Diabetes Mellitus, Type 1 | 01/23 | 04/23 | | |
| Completed | 4 | 76 | RoW | Sitagliptin 100mg, Januvia, Glargine, Lantus, Lispro, Humalog | Hospital de Especialidades, Centro Medico Nacional "La Raza", Instituto Mexicano del Seguro Social, National Polytechnic Institute, Mexico | Type 2 Diabetes | 08/23 | 08/23 | | |
| Recruiting | 4 | 260 | US | Oral Anti-diabetes Drugs alone, metformin, sulfonylureas, pioglitazone, dipeptidyl peptidase-4 (DPP-4) inhibitors, sodium-glucose co-transporter 2 (SGLT2) inhibitors, Basal bolus insulin, glargine, detemir, Supplemental insulin, Humalog, Novolog, Continuous glucose monitoring (CGM), Dexcom | Emory University, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Diabetes Mellitus | 09/24 | 12/24 | | |
